Device Trial Radar · NCT03882671
Development of a Minimally Invasive Seizure Gauge
Last checked: Nov 20, 2026Latest source record: May 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Jan 1, 2019
Primary completion
Dec 31, 2023
Study completion Dec 31, 2023
Sponsor
- Lead sponsor
- Seer Medical Pty LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 20, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The researchers are trying to assess changes in physiological signals before and during seizures.
Conditions
- Epilepsy
Interventions
EpiTel EpilogDevice
EEG recording device
Empatica E4Device
PPG, sweat level, temperature and accelerometry recording device
GENEActivDevice
Temperature, light level and accelerometry recording device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Multimodal Assessment of Physiological Signals During Seizure Events Measurable with Wearable SensorsTime frame: 2-7 days approximately
2 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Seer Medical
Melbourne, Victoria, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.